Brief: BB Biotech Reports Q1 Net Loss Of CHF 21 Million
24/04/2026 06:05
April 24 (Reuters) - BB BIOTECH AG BION.S: REPORTS NET LOSS OF CHF 21 MILLION FOR PERIOD ENDED MARCH 31, 2026 Q1 SHARE PRICE TOTAL RETURN OF +4.1% IN CHF, +5.2% IN EUR AND +3.2% IN USD DIRECT EXPOSURE OF MOST PORTFOLIO COMPANIES TO TARIFFS REMAINS LIMITED Source text: ID:nEQcd6478a Further company coverage: BION.S (Gdansk Newsroom) ((((gdansk.newsroom@thomsonreuters.com ; +48 587785269; ));))
Recent news on Bb Biotech AG
See all newsBrief: BB Biotech Reports Net Profit Of CHF 451 Mln In Q2 2026
Switzerland's BB Biotech Q1 net loss narrows amid portfolio rotation
Brief: BB Biotech Reports Q1 Net Loss Of CHF 21 Million
Brief: BB BIOTECH Q1 Net Income CHF -21 Million
Brief: BB Biotech Says All Proposals Of Board Of Directors Approved At AGM